Test will help match patients with blood cancer to right treatments

05/3/2013 | Boston Globe (tiered subscription model), The

Foundation Medicine has entered a collaboration with Memorial Sloan-Kettering Cancer Center for the development of a test to help identify the best hematologic cancer treatments for individual patients. The test will employ RNA and DNA sequencing to classify hematologic conditions.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care